Skip to main content
Premium Trial:

Request an Annual Quote

Genome Canada and Partners Offer CA $123M for Genomics and Proteomics; Winners to be Announced Tomorrow

NEW YORK, April 12 (GenomeWeb News) - Genome Canada said today that it will grant CA$123 million ($92 million) to large-scale genomics and proteomics projects, and will announce Ontario, Quebec, Prairie region, and British Columbia recipients tomorrow.

 

Half of the funding, distributed through the Applied Genomics and Proteomics Research in Human Health Competition, will come from Genome Canada, the other half from as yet undisclosed partners, a Genome Canada spokeswoman told GenomeWeb. The competition was launched last year after Genome Canada received CA$75 million from the 2003 federal budget.

 

The funding will focus on the development and application of genomics and proteomics tools to improve the prediction and treatment of disease, and on research on the impacts that these tools may have on health and the Canadian healthcare system.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.